301111.SZ
粤万年青
SZSE · Healthcare · C 制造业 · CN
CNY 21.07
−3.04%Year over year
Reported trailing growth
- Revenue
- +11.4%
- EBITDA
- —
- EBIT
- +33.3%
- EPS
- +67.2%
- Free cash flow
- +113.3%
- Operating cash flow
- +238.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.6%
- EBITDA
- -59.6%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -76.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026